News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Thor Halfdanarson: CUP is increasingly precision oncology
Thor Halfdanarson/mayoclinic.org
Mar 22, 2025, 12:06

Thor Halfdanarson: CUP is increasingly precision oncology

Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a post on X:

“CUP oncology is increasingly precision oncology. Patient in 60s, extensive BRG-1 deficient undifferentiated poorly diff carcinoma of unknown primary. Near complete but not durable response to docetaxel/cisplatin/pembro followed by durable response to adagrasib for KRAS G12C mut.”

Thor Halfdanarson

cancer carcinoma CUP oncology OncoDaily Oncology Precision Oncology Thor Halfdanarson
Special Coverage
Science
Aug 24, 2025, 13:47
Myeloma Paper of the Day, August 24th, Suggested by Robert Orlowski
Insight
Aug 24, 2025, 13:46
Marcia Cruz-Correa Highlights Positive Results of Podium-303 Clinical Trial
Voices
Aug 24, 2025, 13:40
Jean-Charles Soria: Circulating Tumor Cells
Blog Posts
Aug 24, 2025, 13:37
Sofiat Akinola: Addressing Global Gaps in Cervical Cancer Screening
Insight
Aug 24, 2025, 13:30
David Planchard Shared Highlights from ESMO Academy 2025
Voices
Aug 24, 2025, 13:17
Make-A-Will Month: Leave a Gift to Fight Childhood Cancer - St. Baldrick's Foundation
Voices
Aug 24, 2025, 13:07
Sebastian Szmit: Two New Important Patrons of The Summit on Cardio-Oncology Excellence 2025
Science
Aug 24, 2025, 12:44
Patrick Hwu: How Can We Make CAR-NK Cell Therapy More Effective Against Tough Cancers?
Societies
Aug 24, 2025, 12:40
Understanding Leptomeningeal Metastatic Disease - WeTrials
Voices
Aug 24, 2025, 12:35
FDA Begins Real-Time Reporting of Adverse Event Data
Opinion
Aug 24, 2025, 12:33
Douglas Flora: Promise of MRD Testing in GI Cancers
Voices
Aug 24, 2025, 12:08
Alique Topalian: CancerCon 2025 Opening Keynote